Physical symptoms from prostate biopsy can cause anxiety

October 23, 2013
Physical symptoms from prostate biopsy can cause anxiety

(HealthDay)—Problematic symptoms of prostate biopsy can lead to increased anxiety in men, even when the biopsy results are negative for cancer, according to research published online Oct. 21 in the Journal of Clinical Oncology.

Julia Wade, Ph.D., of the University of Bristol in the United Kingdom, and colleagues analyzed data from questionnaires completed by 1,144 , among those enrolled in the Prostate Testing for Cancer and Treatment trial, to assess the psychological impact of .

The researchers found that biopsy-related symptoms were minor or not a problem, and overall levels of anxiety and depression were low, for most men. Among 471 men who received a negative biopsy result, those who had biopsy-related symptoms at seven days, including pain, shivers, hematuria, hematochezia, and hemoejaculate, that were problematic had significantly greater anxiety than those who had symptoms that were non-problematic. At 35 days, although symptoms were not reduced, anxiety was lessened.

"Problematic post-biopsy symptoms can lead to increased , distinct from distress related to diagnosis of prostate ," the authors write. "Men and doctors need to consider these additional potential harms of biopsy when deciding whether to initiate prostate-specific antigen testing."

Explore further: Benefits of prostate-specific antigen testing remain unclear

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Benefits of prostate-specific antigen testing remain unclear

July 20, 2012

(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, according to a provisional ...

PCA3 assay ups predictive accuracy for repeat biopsy

June 13, 2013

(HealthDay)—For men with at least one prior negative biopsy, urinary PCA3 scores, together with serum prostate-specific antigen and other clinical information, improve the prediction accuracy for repeat biopsy outcome, ...

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.